Congress Looks to Beef up Agency’s Power to Withdraw Unproven AA Drugs
The House Energy and Commerce Committee is considering a pair of rival bills, one Democratic and one Republican, to reform the AA process.
Recent Headlines
Recent Headlines
Subscribe today for access to
Articles and Reports
Already a member? Log in here
Already a member? Log in here
How CSF Tests May Help Recruitment for Alzheimer’s Drug Clinical Trials
A recent study shows these tests may make it easier and more cost-effective to identify patients for studies of new PET treatments.
New Act Would Mean Wider Medicare Coverage of Genetic Cancer Screening
Legislation would require Medicare to cover genomic cancer testing and follow-up screening for those with a family history of cancer.
Already a member? Log in here
OIG Gives Green Light to Employee Tuition Reimbursement Benefits
Could paying the tuition costs of employees seeking certification put you at risk of violating the AKS?
Three Key Changes Your Lab Staff Need to Know About
CMS recently announced some important changes affecting PAMA price reporting, along with a list of 17 new PLA codes that will be recognized.
Agency Continues Crack Down on Unauthorized COVID-19 Tests
On Jan. 11, the FDA warned consumers not to use COVID-19 tests from LuSys Laboratories, as they have not been approved for use in the US.
Florida Treatment Center Settles HIPAA Right of Access Enforcement Action for $160,000
Recent case shows that you better respond promptly when patients request access to their medical records.
Already a member? Log in here
Already a member? Log in here
Already a member? Log in here